OCEANIC STROKE Trial Phase 3 Trial
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
OCEANIC STROKE Trial Phase 3 Trial
-
Narrated by:
-
By:
Summary
Audio overview, where we'll be discussing the key findings from the late-breaking OCEANIC-STROKE phase 3 trial, presented by Dr. Sharma. This was a pivotal study focusing on the risks and benefits of asundexian, a factor XIa inhibitor, in acute non-cardioembolic ischemic stroke and high-risk transient ischemic attack (TIA).
adbl_web_anon_alc_button_suppression_c
No reviews yet